...
首页> 外文期刊>Stem cells international >Head to Knee: Cranial Neural Crest-Derived Cells as Promising Candidates for Human Cartilage Repair
【24h】

Head to Knee: Cranial Neural Crest-Derived Cells as Promising Candidates for Human Cartilage Repair

机译:头部到膝盖:颅神经嵴衍生的细胞作为人类软骨修复的有希望的候选人

获取原文
           

摘要

A large array of therapeutic procedures is available to treat cartilage disorders caused by trauma or inflammatory disease. Most are invasive and may result in treatment failure or development of osteoarthritis due to extensive cartilage damage from repeated surgery. Despite encouraging results of early cell therapy trials that used chondrocytes collected during arthroscopic surgery, these approaches have serious disadvantages, including morbidity associated with cell harvesting and low predictive clinical outcomes. To overcome these limitations, adult stem cells derived from bone marrow and subsequently from other tissues are now considered as preferred sources of cells for cartilage regeneration. Moreover, with new evidence showing that the choice of cell source is one of the most important factors for successful cell therapy, there is growing interest in neural crest-derived cells in both the research and clinical communities. Neural crest-derived cells such as nasal chondrocytes and oral stem cells that exhibit chondrocyte-like properties seem particularly promising in cartilage repair. Here, we review the types of cells currently available for cartilage cell therapy, including articular chondrocytes and various mesenchymal stem cells, and then highlight recent developments in the use of neural crest-derived chondrocytes and oral stem cells for repair of cartilage lesions.
机译:一系列大量治疗程序可用于治疗由创伤或炎症疾病引起的软骨障碍。大多数是侵袭性的,可能导致治疗失败或骨关节炎的发育,由于重复手术的广泛软骨损伤。尽管令人鼓舞的早期细胞疗法试验,但在关节镜手术期间收集的软骨细胞,这些方法具有严重的缺点,包括与细胞收集和低预测临床结果相关的发病率。为了克服这些限制,从骨髓和随后来自其他组织的成体干细胞现在被认为是软骨再生的优选细胞来源。此外,通过新的证据表明,细胞来源的选择是成功细胞疗法的最重要因素之一,对研究和临床社区的神经嵴衍生细胞产生了越来越多的兴趣。神经嵴衍生的细胞,如鼻软骨细胞和口服干细胞,其表现出软骨细胞样性能似乎在软骨修复中具有特别希望。在这里,我们审查目前可用于软骨细胞疗法的细胞类型,包括关节软骨细胞和各种间充质干细胞,然后突出近来使用神经嵴衍生的软骨细胞和口服干细胞来修复软骨病变的近期发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号